OptimizeRx Stock Down 30% in a Month: Should Investors Hold or Fold?
OPRX Boosts DSP Revenue Potential While Navigating Near-Term Headwinds
OptimizeRx Cuts Revenue Outlook: Will Pressures Ease Ahead?
OptimizeRx Q1 Earnings Call Highlights
OptimizeRx Corporation (OPRX) Q1 2026 Earnings Call Transcript
OptimizeRx Corp. (OPRX) Surpasses Q1 Earnings and Revenue Estimates
OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
OptimizeRx Expands EHR Advertising Reach With New DSP Integration
OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale
OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale
Should You Add OPRX Stock to Your Portfolio Pre-Q1 Earnings?
Earnings Preview: OptimizeRx Corp. (OPRX) Q1 Earnings Expected to Decline
Are Investors Undervaluing OptimizeRx (OPRX) Right Now?
OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report
OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report
OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 p.m. ET
Cadence Design Systems (CDNS) Q1 Earnings and Revenues Top Estimates
OptimizeRx vs. GoodRx: Which Digital Health Stock is the Better Buy?
Will Enterprise Deals & MedTech Momentum Fuel OPRX's Growth Engine?
Can OptimizeRx's Cash Strength Cushion Near-Term Headwinds?
OPRX Trades at a Discount to Industry: How to Approach the Stock Now?
Should Value Investors Buy OptimizeRx (OPRX) Stock?
OPRX Cuts Revenue Outlook: Temporary Reset or Structural Concern?
OptimizeRx Appoints Mary Varghese Presti to Board of Directors
OptimizeRx (NASDAQ:OPRX) vs. Synopsys (NASDAQ:SNPS) Head-To-Head Analysis
Are Investors Undervaluing OptimizeRx (OPRX) Right Now?
New Strong Buy Stocks for April 1st
Best Value Stocks to Buy for April 1st
OptimizeRx Corp. (NASDAQ:OPRX) Receives Consensus Recommendation of “Moderate Buy” from Analysts
OptimizeRx (OPRX) Soars 5.9%: Is Further Upside Left in the Stock?
Best Value Stocks to Buy for March 24th
New Strong Buy Stocks for March 24th
Is OptimizeRx (OPRX) Stock Undervalued Right Now?
Best Value Stocks to Buy for March 16th
What Moved Markets This Week
OptimizeRx Warns Of Volatility From 'Most Favored Nation' Pricing Uncertainty
OptimizeRx Corporation (OPRX) Q4 2025 Earnings Call Transcript
OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates
UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
Brokerages Set OptimizeRx Corp. (NASDAQ:OPRX) Price Target at $21.00
OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET
Strength Seen in OptimizeRx (OPRX): Can Its 7.5% Jump Turn into More Strength?
OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing
OptimizeRx Stock: A Buy-The-Dip Opportunity For This Above-Average Growth Story
OptimizeRx (NASDAQ:OPRX) Insider Edward Stelmakh Sells 1,388 Shares of Stock
OptimizeRx Continues Expansion of the Company's Point-Of-Care Network
New Strong Buy Stocks for Nov. 17: ROKU, AVPT, and More
OptimizeRx Corporation (OPRX) Q3 2025 Earnings Call Transcript
OptimizeRx Corp. (OPRX) Tops Q3 Earnings and Revenue Estimates